Thu, April 6, 2017
Wed, April 5, 2017
Tue, April 4, 2017
Mon, April 3, 2017
Fri, March 31, 2017
Thu, March 30, 2017
Wed, March 29, 2017
Tue, March 28, 2017
Mon, March 27, 2017
Fri, March 24, 2017
Thu, March 23, 2017

Martin Auster Initiated (BMRN) at Hold and Held Target at $92 on, Mar 30th, 2017


//stocks-investing.news-articles.net/content/201 .. hold-and-held-target-at-92-on-mar-30th-2017.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


Martin Auster of UBS, Initiated "BioMarin Pharmaceutical Inc." (BMRN) at Hold and Held Target at $92 on, Mar 30th, 2017.

Martin has made no other calls on BMRN in the last 4 months.



There are 2 other peers that have a rating on BMRN. Out of the 2 peers that are also analyzing BMRN, 0 agree with Martin's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Martin


  • Matthew Harrison of "Morgan Stanley" Initiated at Buy and Held Target at $110 on, Tuesday, February 7th, 2017
  • Kennen MacKay of "Credit Suisse" Initiated at Buy with Decreased Target to $107 on, Monday, January 23rd, 2017

Publication Contributing Sources